|
|
John C. Atherton, Martin J. Blaser
J Clin Invest. 2009;
119(9):2475
doi:10.1172/JCI38605
Abstract |
Full text
| PDF
| Supplemental material
H
umans have been colonized by Helicobacter pylori for at least 50,000 years and probably throughout their evolution. H. pylori has adapted to humans, colonizing children and persisting throughout life. Most strains possess factors that subtly modulate the host environment, increasing the risk of peptic ulceration, gastric adenocarcinoma, and possibly other diseases. H. pylori genes encoding these and other factors rapidly evolve through mutation and recombination, changing the bacteria-host interaction. Although immune and physiologic responses to H. pylori also contribute to pathogenesis, humans have evolved in concert with the bacterium, and its recent absence throughout the life of many individuals has led to new human physiological changes. These may have contributed to recent increases in esophageal adenocarcinoma and, more speculatively, other modern diseases.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(41)
| Title and authors |
Publication |
Year |
Infección por Helicobacter pylori
C. Gargallo, P. Aranguren García, F. Gomollón
|
Medicine - Programa de Formación Médica Continuada Acreditado
|
2012 |
High frequency of Helicobacter pylori in the esophageal mucosa of dyspeptic patients and its possible association with histopathological alterations
Monica Contreras, Víctor Salazar, María Alexandra García-Amado, Nelson Reyes, Miguel Aparcero, Olga Silva, Denny Castro, Roberto Romero, Pulchérie Gueneau, Fabián Michelangeli
|
International Journal of Infectious Diseases
|
2012 |
The human microbiome: at the interface of health and disease
Ilseung Cho, Martin J. Blaser
|
Nat Rev Genet
|
2012 |
Association Between Gastric Helicobacter pylori Colonization and Glycated Hemoglobin Levels
Y. Chen, M. J. Blaser
|
J. Infect. Dis.
|
2012 |
Infection, immunoregulation, and cancer
Graham A. W. Rook, Angus Dalgleish
|
Immunological Reviews
|
2011 |
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma
Sung Soo Kim, Victoria E. Ruiz, Jaqueline D. Carroll, Steven F. Moss
|
Cancer Letters
|
2011 |
The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin.
Fritz Francois, Jatin Roper, Neal Joseph, Zhiheng Pei, Aditi Chhada, Joshua R Shak, Asalia Z Olivares de Perez, Guillermo I Perez-Perez, Martin J Blaser
|
BMC Gastroenterol
|
2011 |
Helicobacter pylori with stronger intensity of CagA phosphorylation lead to an increased risk of gastric intestinal metaplasia and cancer.
Chiao-Hsiung Chuang, Hsiao-Bai Yang, Shew-Meei Sheu, Kuei-Hsiang Hung, Jiunn-Jong Wu, Hsiu-Chi Cheng, Wei-Lun Chang, Bor-Shyang Sheu
|
BMC Microbiol
|
2011 |
HelicoVax: Epitope-based therapeutic Helicobacter pylori vaccination in a mouse model
Steven F. Moss, Leonard Moise, Dong Soo Lee, Woojin Kim, Songhua Zhang, Jinhee Lee, Arlin B. Rogers, William Martin, Anne S. De Groot
|
Vaccine
|
2011 |
Down-regulation of Bcl-2 is mediated by NF-κB activation inHelicobacter pylori-induced apoptosis of gastric epithelial cells
Sang Hui Chu, Joo Weon Lim, Dong Goo Kim, Eung-Seok Lee, Kyung Hwan Kim, Hyeyoung Kim
|
Scand J Gastroenterol
|
2011 |
|